TB-500 - TB-500 Standard Protocol
protocol
Verified
Tissue repair and regeneration Thymosin beta-4 fragment with healing and regenerative properties
Chemical Information
Source:
SSRP
Clinical Information
Dosing:
2.5-5mg twice weekly subcutaneous 2-3 times per week
Safety Information
Contraindications:
- Active cancer
Last updated: 3/28/2025 at 6:41:48 AM
Version: 1
Detailed Information
Primary Uses
Source Information
SSRP
Last updated: March 28, 2025
Version: 1